INHIBITING THE ERB3/HER3 TYROSINE KINASE DOMAIN AS AN OVERLOOKED THERAPEUTIC TARGET IN BREAST CANCER

$568,410FY2010Department of the ArmyDOD

Trustees Of The University Of Pennsylvania, The

Investigators

INHIBITING THE ERB3/HER3 TYROSINE KINASE DOMAIN AS AN OVERLOOKED THERAPEUTIC TARGET IN BREAST CANCER · GrantIndex